<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040396</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Early indicators of severity in dengue virus infection</dc:title>
<dc:description xml:lang="en">Objective. To identify clinical markers of severity in dengue, different from those of major hemorrhage. Design. Cross-sectional study. Population and methods. Patients with a diagnosis of dengue infection admitted to hospitals in Santander (Colombia) during the years 1993 to 1998 were studied. On admittance or during hospitalization, patients were classified as cases of dengue hemorrhagic fever (DHF) or dengue fever (DF). Clinical findings differing from those of major hemorrhage were recorded in the emergency room and during the first assessment at hospitalization. The association between these findings and the outcome of DHF were evaluated using univariate and multivariate analyses. Results. 891 patients (DF: 420; DHF: 471) were included in the study. Associations were found between DHF and the following signs and symptoms: vomiting (OR: 1.89; 95% CI: 1.37-2.6; p = 0.0001); gingival hemorrhage (OR: 1.55; 95% CI: 1.11-2.18; p = 0.01); epistaxis (OR: 1.78; 95% CI: 1.28-2.48; p = 0.001); hepatomegaly (OR: 2.56; 95% CI: 1.61-4.07; p &lt; 0.0001); microscopic hematuria (OR: 2.33; 95% CI: 1.36-4; p = 0.002); and rash (OR: 1.36; 95% CI: 1.04-1.77; p = 0.02). The hematocrit in the emergency room and on the first day of hospitalization was significantly higher in the group with DHF (p &lt; 0.001, in both observations). On multivariate analysis, the hematocrit from DHF patients obtained in the emergency room was higher than that from DF, independently of the other relevant variables (difference: 3.65; 95% CI: 2.81-4.49). Conclusion. Under the study conditions, there was an association between early clinical findings and DHF. These results must be evaluated in a cohort study (AU)</dc:description>
<dc:creator>Díaz-Quijano, Fredi Alexander</dc:creator>
<dc:creator>Martínez-Vega, Ruth Aralí</dc:creator>
<dc:creator>Villar-Centeno, Luis Ángel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Identificar los marcadores clínicos de gravedad en el dengue, diferentes a hemorragias mayores. Diseño. Estudio de corte transversal. Población y métodos. Pacientes con diagnóstico de dengue que ingresaron durante el período 1993-1998 en hospitales de Santander (Colombia). Al ingreso, o durante su estancia, se clasificaron los casos de dengue hemorrágico (DH) o dengue clásico (DC). Se registraron los hallazgos clínicos, diferentes a hemorragias mayores, encontrados en urgencias y durante la primera evaluación hospitalaria. Se evaluó la asociación entre estos hallazgos y el desenlace de DH. Resultados. Se incluyó a 891 pacientes (DC: 420, DH: 471). Hubo asociación entre DH y un registro en el ingreso de vómito (odds ratio [OR]: 1,89; intervalo de confianza del 95 % [IC 95%]: 1,37-2,6; p = 0,0001); hemorragia gingival (OR: 1,55; IC 95%: 1,11-2,18; p = 0,01); epistaxis (OR: 1,78; IC 95%: 1,28-2,48; p 5 0,001); hepatomegalia (OR: 2,56; IC 95%: 1,61-4,07; p &lt; 0,0001); hematuria microscópica (OR: 2,33; IC 95%: 1,36-4; p = 0,002), y exantema (OR: 1,36; IC 95%: 1,04-1,77; p = 0,02). Los valores de hematócrito tomados en urgencias y en el primer día de hospitalización fueron significativamente más elevados en el grupo con DH (p &lt; 0,001, en ambas observaciones). En un análisis multivariado, el hematócrito de urgencias de los pacientes con DH superó al de aquellos con DC, independientemente de las otras variables estudiadas (diferencia: 3,65; IC 95%: 2,81-4,49). Conclusión. Se evidencia una asociación entre los hallazgos clínicos tempranos diferentes a hemorragias mayores y DH. Estos resultados deben evaluarse en un estudio de cohortes (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;23(9): 529-532, nov. 2005. tab</dc:source>
<dc:identifier>ibc-040396</dc:identifier>
<dc:title xml:lang="es">Indicadores tempranos de gravedad en el dengue</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d6550^s22083</dc:subject>
<dc:subject>^d33342^s22012</dc:subject>
<dc:subject>^d28002^s22080</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28052^s22080</dc:subject>
<dc:subject>^d3727^s22080</dc:subject>
<dc:subject>^d3727^s22012</dc:subject>
<dc:subject>^d3727^s22011</dc:subject>
<dc:subject>^d33342^s22080</dc:subject>
<dc:subject>^d6686^s22080</dc:subject>
<dc:subject>^d3728^s22052</dc:subject>
<dc:subject>^d18001</dc:subject>
<dc:type>article</dc:type>
<dc:date>200511</dc:date>
</metadata>
</record>
</ibecs-document>
